BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11396137)

  • 1. Selective activity of BS-RNase against anaplastic thyroid cancer.
    Kotchetkov R; Cinatl J; Krivtchik AA; Vogel JU; Matousek J; Pouckova P; Kornhuber B; Schwabe D; Cinatl J
    Anticancer Res; 2001; 21(2A):1035-42. PubMed ID: 11396137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cytotoxic activity of a novel ribonucleoside diphosphate reductase inhibitor MDL-101,731 against thyroid cancer in vitro.
    Kotchetkov R; Krivtchik AA; Cinatl J; Kornhuber B; Cinatl J
    Folia Biol (Praha); 1999; 45(5):185-91. PubMed ID: 10730887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.
    Soucek J; Poucková P; Zadinová M; Hlousková D; Plocová D; Strohalm J; Hrkal Z; Oleár T; Ulbrich K
    Neoplasma; 2001; 48(2):127-32. PubMed ID: 11478693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
    Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
    Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor action of bovine seminal ribonuclease.
    Soucek J; Poucková P; Matousek J; Stockbauer P; Dostál J; Zadinová M
    Neoplasma; 1996; 43(5):335-40. PubMed ID: 8996554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors.
    Laccetti P; Portella G; Mastronicola MR; Russo A; Piccoli R; D'Alessio G; Vecchio G
    Cancer Res; 1992 Sep; 52(17):4582-6. PubMed ID: 1511425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor action of bovine seminal ribonuclease. Cytostatic effect on human melanoma and mouse seminoma.
    Poucková P; Soucek J; Jelínek J; Zadinová M; Hlousková D; Polívková J; Navrátil L; Cinátl J; Matousek J
    Neoplasma; 1998; 45(1):30-4. PubMed ID: 9604999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis.
    Spalletti-Cernia D; Sorrentino R; Di Gaetano S; Arciello A; Garbi C; Piccoli R; D'Alessio G; Vecchio G; Laccetti P; Santoro M
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2900-7. PubMed ID: 12788904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
    Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
    Luong QT; O'Kelly J; Braunstein GD; Hershman JM; Koeffler HP
    Clin Cancer Res; 2006 Sep; 12(18):5570-7. PubMed ID: 17000694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
    Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
    Kim R; Tanabe K; Uchida Y; Emi M; Toge T
    Int J Mol Med; 2003 Jun; 11(6):799-804. PubMed ID: 12736725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
    Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabeled annexin V for imaging apoptosis in radiated human follicular thyroid carcinomas--is an individualized protocol necessary?
    Grosse J; Grimm D; Westphal K; Ulbrich C; Moosbauer J; Pohl F; Koelbl O; Infanger M; Eilles C; Schoenberger J
    Nucl Med Biol; 2009 Jan; 36(1):89-98. PubMed ID: 19181273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
    Klopper JP; Berenz A; Hays WR; Sharma V; Pugazhenthi U; Janssen J; Singh M; Bissonnette RP; Haugen BR
    Clin Cancer Res; 2008 Jan; 14(2):589-96. PubMed ID: 18223235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.